MiNK Therapeutics, Inc. (INKT)
(Real Time Quote from BATS)
$0.78 USD
+0.01 (0.65%)
Updated Sep 12, 2024 12:12 PM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.08 |
EPS Last Quarter | -0.07 |
Last EPS Surprise | 30.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.33 |
Next Year | -0.35 |
EPS (TTM) | -0.49 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.08 | -0.08 | -0.33 | -0.35 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.08 | -0.08 | -0.33 | -0.35 |
High Estimate | -0.07 | -0.07 | -0.32 | -0.35 |
Low Estimate | -0.08 | -0.08 | -0.34 | -0.35 |
Year ago EPS | -0.15 | -0.16 | -0.65 | -0.33 |
Year over Year Growth Est. | 46.67% | 50.00% | 49.23% | -6.06% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 2 | 2 | 2 | 1 |
Up Last 60 Days | 2 | 2 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.08 | -0.08 | -0.33 | -0.35 |
7 Days Ago | -0.08 | -0.08 | -0.33 | -0.35 |
30 Days Ago | -0.10 | -0.10 | -0.42 | -0.38 |
60 Days Ago | -0.10 | -0.10 | -0.42 | -0.38 |
90 Days Ago | -0.10 | -0.10 | -0.42 | -0.38 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.08 | -0.08 | -0.33 | -0.35 |
Zacks Consensus Estimate | -0.08 | -0.08 | -0.33 | -0.35 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.07 | -0.11 | -0.16 | -0.15 | NA |
Estimate | -0.10 | -0.16 | -0.15 | -0.18 | NA |
Difference | 0.03 | 0.05 | -0.01 | 0.03 | 0.03 |
Surprise | 30.00% | 31.25% | -6.67% | 16.67% | 17.81% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more